Dorzolamide + Timolol
Nodom Combi contains two active substances: dorzolamide and timolol.
Nodom Combi is used to lower high pressure in the eye in the treatment of glaucoma when treatment with eye drops containing only a beta-adrenergic blocker is not enough.
In case of doubt, whether Nodom Combi can be used, consult a doctor or pharmacist.
Before starting to use Nodom Combi, discuss it with your doctor.
Tell your doctor about all current or past eye disorders and diseases, especially if you have:
Before surgery, tell your doctor that you are using Nodom Combi, as timolol may affect the action of certain anesthetics.
Also, inform your doctor about any allergies or allergic reactions, such as hives, facial swelling, lip swelling, tongue and/or throat swelling, which can cause difficulty breathing or swallowing.
Tell your doctor if you have muscle weakness or have been diagnosed with myasthenia.
If you experience any eye irritation or new eye problems, such as eye redness or eyelid swelling, contact your doctor immediately.
If you suspect that Nodom Combi is causing an allergic reaction or hypersensitivity (e.g., skin rash, severe skin reaction, or eye redness and itching), discontinue use of this medicine and contact your doctor immediately.
Tell your doctor about any infection or injury to the eyeball, eye surgery, other reactions, or worsening of symptoms.
When Nodom Combi is instilled into the eye, it may cause systemic effects.
If you wear soft contact lenses, consult your doctor before using this medicine.
Experience with Nodom Combi in infants and children is limited.
In studies where Nodom Combi was used, the effect of the medicine in elderly patients and younger patients was similar.
Tell your doctor if you have current or past liver disorders.
Nodom Combi may affect the action of other medicines or other medicines used by the patient may affect the action of Nodom Combi, including other eye drops used to treat glaucoma.
Tell your doctor if you are taking or plan to take blood pressure-lowering medicines, heart medicines, or diabetes medicines.
Tell your doctor or pharmacist about any other medicines you are taking or plan to take. This is especially important if you:
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
Do not use Nodom Combi during pregnancy.
Do not use Nodom Combi during breastfeeding. Nodom Combi may pass into breast milk. During breastfeeding, consult your doctor before taking any medicine.
Before taking any medicine, consult your doctor or pharmacist.
No studies have been conducted on the effect on the ability to drive or operate machines. Some side effects associated with the use of Nodom Combi, such as blurred vision, may affect the ability to drive or operate machines. Patients who feel unwell or have blurred vision should not drive or operate machines until these symptoms have resolved.
The medicine contains 0.075 mg of benzalkonium chloride per 1 ml of solution.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before instillation and wait at least 15 minutes before reinserting. Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If you experience any abnormal sensations in the eye, stinging, or eye pain after using the medicine, contact your doctor.
Always use this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Your doctor will determine the correct dosage and duration of treatment.
The recommended dose is one drop into the affected eye(s) twice daily, for example, in the morning and evening.
If you are using Nodom Combi with other eye drops, wait at least 10 minutes between administering Nodom Combi and the other medicine.
Do not change the dose of the medicine without consulting your doctor.
Do not touch the eye or the area around the eye with the dropper tip. It may become contaminated with bacteria, which can cause an eye infection leading to serious eye damage, even loss of vision. To avoid contaminating the dropper, do not touch the tip to any surface. If you suspect that the medicine may have become contaminated or you have developed an eye infection, contact your doctor immediately about continuing to use this bottle.
To ensure proper dosing, do not enlarge the dropper tip.
It is recommended to wash your hands before administering the drops.
Administering the drops may be easier if you do it in front of a mirror.
If the drop does not get into the eye, try again.
If too many drops are administered to the eye or the contents of the bottle are swallowed, dizziness, breathing difficulties, or a feeling of slow heart rate may occur.
Contact your doctor immediately.
It is important to use Nodom Combi as directed by your doctor.
If you miss a dose, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and return to your normal dosing schedule.
Do not take a double dose to make up for a missed dose.
If you want to stop using the medicine, discuss it with your doctor first.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Nodom Combi can cause side effects, although not everybody gets them.
Continue using the drops unless severe side effects occur. If you are unsure, contact your doctor or pharmacist. Do not stop using Nodom Combi without consulting your doctor.
Generalized allergic reactions include swelling under the skin, which can occur in areas such as the face and limbs, and can narrow the airways, causing difficulty swallowing or breathing, hives, or itchy rash, local and generalized rash, itching, severe, sudden, life-threatening allergic reaction.
The following side effects have been reported with Nodom Combi or one of its ingredients during clinical trials or after marketing:
Very common(may affect more than 1 in 10 people):
Burning and stinging in the eye/eyes, change in taste sensation.
Common(may affect up to 1 in 10 people):
Eye redness or around the eye, tearing or feeling of itching in the eye/eyes, corneal erosion (damage to the front layer of the eyeball), swelling or irritation of the eye/eyes or around the eye/eyes, feeling of a foreign body in the eye, decreased corneal sensitivity (lack of feeling that something has entered the eye and lack of feeling pain), eye pain, feeling of dryness of the eyeball, blurred vision, headache, sinusitis (feeling of tension and fullness in the nose), nausea (nausea), weakness and fatigue.
Uncommon(may affect up to 1 in 100 people):
Dizziness, depression, uveitis, vision disorders, including changes in refraction (in some cases due to withdrawal of pupil-constricting medicines), slow heart rate, loss of consciousness, breathing difficulties (apnea), indigestion, kidney stones (often with sudden onset of severe, crampy pain in the lower back or side, groin, or abdomen).
Rare(may affect up to 1 in 1,000 people):
Systemic lupus erythematosus (an immune system disease that can cause inflammation of internal organs), tingling and numbness of hands or feet, sleep problems, nightmares, memory loss, worsening of myasthenia symptoms (muscle disorder), decreased libido, separation of the layer of the eye under the retina and containing blood vessels after filtration surgery (may cause vision disorders), drooping eyelids (causing the eye to be half-closed), double vision, eyelid sticking together, corneal edema (causing vision disorders), low eye pressure, ringing in the ears, low blood pressure, changes in heart rhythm or rate, chest pain, congestive heart failure (heart disease characterized by shortness of breath and swelling of the feet and ankles due to fluid retention), swelling (fluid accumulation), cerebral ischemia (reduced blood flow to the brain), chest pain, palpitations (rapid and/or irregular heartbeat), myocardial infarction, Raynaud's phenomenon, swelling of hands or cold hands and feet, decreased blood flow to the hands and feet, muscle cramps in the legs or leg pain when walking (intermittent claudication), shortness of breath, feeling of lack of air, runny nose or feeling of nasal congestion, nosebleeds, bronchospasm (narrowing of the airways in the lungs causing difficulty breathing), cough, throat irritation, dry mouth, diarrhea, contact dermatitis, hair loss, white-silver skin rash (psoriasis-like rash), Peyronie's disease (may cause penis curvature), allergic reactions such as rash, hives, itching, in rare cases possible swelling of lips, eyes, and mouth, wheezing, or severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis).
As with other eye medicines, timolol is absorbed into the bloodstream, which can cause side effects similar to those observed after oral administration of beta-adrenergic blockers. Side effects occur less frequently after topical administration of eye drops than after oral administration or injections.
Among the additional side effects listed, reactions typical of the therapeutic group of beta-adrenergic blockers used in ophthalmic diseases are included.
Frequency not known(cannot be estimated from the available data):
Low blood sugar, heart failure, heart rhythm disorders, abdominal pain, vomiting, muscle pain unrelated to physical exertion, sexual function disorders, shortness of breath, feeling of a foreign body in the eye (feeling that something is in the eye), hallucination, strong heartbeat that may be rapid or irregular (palpitations), rapid heartbeat, increased blood pressure.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the bottle and carton after: EXP. The expiry date refers to the last day of the month stated.
The inscription on the packaging after the abbreviation EXP indicates the expiry date, and after the abbreviation Lot indicates the batch number.
There are no special precautions for storage temperature of the medicinal product.
The shelf life after opening the bottle is 28 days. Therefore, after 4 weeks from opening the bottle, it should be discarded, even if some solution remains. To make it easier to remember the opening date of the bottle, write it on the carton.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Nodom Combi is a sterile, clear, slightly viscous, colorless aqueous solution.
It is available in MDPE bottles with an LDPE dropper and an HDPE cap with a tamper-evident seal, containing 5 ml of eye drop solution.
Pack sizes: 1, 3, or 6 bottles of 5 ml each.
Not all pack sizes may be marketed.
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
Phone: +48 22 364 61 01
Famar S.A., Plant A
63 Agiou Dimitriou Street, 174 56 Alimos
Greece
Pharmathen S.A.
6 Dervenakion str., 15351 Pallini, Attiki
Greece
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
Date of last revision of the leaflet:April 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.